Expeditors International of Wshngtn Inc vs GeneDx Holdings Corp — how do they compare? Expeditors International of Wshngtn Inc trades at $177.4 (market cap $23.27B), while GeneDx Holdings Corp trades at $81.98 (market cap $2.32B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 10× GeneDx Holdings Corp's market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| EXPD | WGS | |
|---|---|---|
Market Cap | $23.27B | $2.32B |
Sector | Industrials | Technology |
52-Week High | $182.80 | $167.51 |
52-Week Low | $113.13 | $34.51 |
Enterprise Value | $22.80B | $2.35B |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.
Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.
Trailing returns across standard periods
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →